All humans have a diverse set of blood stem cell types which dictate the composition and function of our blood and immune cells and ultimately help govern overall health.
Beta Bionics raises $204M in IPO
Beta Bionics began trading on Thursday after filing to go public in early January. The diabetes technology firm raised $204 million in an upsized initial